Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01999738
Title Folic Acid-Tubulysin Conjugate EC1456 In Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Endocyte
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Phoenix Arizona 85054 United States Details
Honor Health Scottsdale Arizona 85258 United States Details
University of Arizona Cancer Center Tucson Arizona 85719 United States Details
City of Hope Duarte California 91010 United States Details
Northwestern University Robert H. Lurie Comprehensive Cancer Center Chicago Illinois 60611 United States Details
IU Health Goshen Center for Cancer Care Goshen Indiana 46526 United States Details
Indiana University Cancer Center Indianapolis Indiana 46202 United States Details
Horizon BioAdvance Lafayette Indiana 47905 United States Details
University of Maryland-Greenebaum Cancer Center Baltimore Maryland 21201-1595 United States Details
Henry Ford Hospital - Josephine Ford Cancer Center Detroit Michigan 48202 United States Details
Roswell Park Cancer Institute Buffalo New York 14203 United States Details
Weill Cornell Medical College New York New York 10021 United States Details
University Hospitals Case Medical Center - Seidman Cancer Center Cleveland Ohio 44106 United States Details
Westchase Clinical Associates Houston Texas 77042 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77230 United States Details
University of Vermont Cancer Center Burlington Vermont 05401 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field